Skip to content

A clinical trial for assessment of Dexmedetomidine as an adjuvant to ropivacaine in ultrasound-guided Erector spinae plane block in paediatric abdominal surgeries.

A randomized controlled trial to assess the efficacy of dexmedetomidine as an adjuvant to ropivacaine in ultrasound guided erector spinae plane block in paediatric abdominal surgeries.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069257
Enrollment
60
Registered
2024-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified Health Condition 2: K00-K95- Diseases of the digestive system Health Condition 3: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Ultrasound guided Erector Spinae plane block using Dexmedetomidine as an adjuvant to Ropivacaine: 0.2% Ropivacaine + Dexmedetomidine 0.5 mcg/kg (1ml) to a total volume of o.5 ml / kg on

Sponsors

Department of Anaesthesiology and Critical Care Jawaharlal Nehru Medical College AMU Aligarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consent of patient( >9yrs,parents/guardian ASA grade 1& 2 Weight between 10 kg to 30 kg Patients undergoing elective abdominal surgery under general anaesthesia

Exclusion criteria

Exclusion criteria: No consent Allergy history Skin infection Deranged blood clotting Congenital abnormalities Systemic diseases

Design outcomes

Primary

MeasureTime frame
Time to first rescue analgesic.Timepoint: 24 hrs

Secondary

MeasureTime frame
1.Intraoperative & postoperative opioid requirement 2.Postoperative pain score using CHEOPS scale 3.intraoperative hemodynamic parameters 4.Effect on emergence delirium 5.Complications if anyTimepoint: 1o min, 30 min, 60 min postoperatively & hourly upto 4 hrs & 6 hourly upto 24 hrs postoperatively

Countries

India

Contacts

Public ContactPooja Kumari Singh

Aligarh Muslim University

kazmifarah@gmail.com9897067670

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026